Symptom-Onset Dosing of Sertraline for the Treatment of Premenstrual Dysphoric Disorder: A Randomized Clinical Trial

Item

http://www.wikidata.org/entity/Q36737606

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Symptom-Onset Dosing of Sertra ...... r: A Randomized Clinical Trial

@ast

Symptom-Onset Dosing of Sertra ...... r: A Randomized Clinical Trial

@en

type

Item

label

Symptom-Onset Dosing of Sertra ...... r: A Randomized Clinical Trial

@ast

Symptom-Onset Dosing of Sertra ...... r: A Randomized Clinical Trial

@en

prefLabel

Symptom-Onset Dosing of Sertra ...... r: A Randomized Clinical Trial

@ast

Symptom-Onset Dosing of Sertra ...... r: A Randomized Clinical Trial

@en

P1476

Symptom-Onset Dosing of Sertra ...... r: A Randomized Clinical Trial

@en

P2093

Brian Merry

http://www.w3.org/2001/XMLSchema#string

Kari Van Steenburgh

http://www.w3.org/2001/XMLSchema#string

Margaret Altemus

http://www.w3.org/2001/XMLSchema#string

Susan G Kornstein

http://www.w3.org/2001/XMLSchema#string

P2860

Selective serotonin reuptake inhibitors for premenstrual syndrome

Selective serotonin reuptake inhibitors directly alter activity of neurosteroidogenic enzymes

Increase in the cerebrospinal fluid content of neurosteroids in patients with unipolar major depression who are receiving fluoxetine or fluvoxamine

Fluoxetine and norfluoxetine stereospecifically and selectively increase brain neurosteroid content at doses that are inactive on 5-HT reuptake

The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10

Premenstrual dysphoric disorder: evidence for a new category for DSM-5

Early and delayed onset of response to antidepressants in individual trajectories of change during treatment of major depression: a secondary analysis of data from the Genome-Based Therapeutic Drugs for Depression (GENDEP) study.

Criteria for premenstrual dysphoric disorder: secondary analyses of relevant data sets

Luteal phase sertraline treatment for premenstrual dysphoric disorder. Results of a double-blind, placebo-controlled, crossover study.

Interruption of selective serotonin reuptake inhibitor treatment. Double-blind, placebo-controlled trial.

P304

1037-1044

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1001/JAMAPSYCHIATRY.2015.1472

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Ralitza Gueorguieva

Kimberly Ann Yonkers

P577

2015-09-09T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26351969

http://www.w3.org/2001/XMLSchema#string

P932

4811029

http://www.w3.org/2001/XMLSchema#string